| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.19 | 0.4 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |